About Hegira Health Inc
Services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Prescribes buprenorphine; Prescribes naltrexone; Lofexidine or Clonidine detoxification
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Lofexidine; Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State Substance use treatment agency; The Joint Commission
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicare; Medicaid; Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid; SAMHSA funding/block grants
Payment Assistance Available
Payment assistance (check with facility for details); Sliding fee scale (fee is based on income and other factors)
Special Programs/Groups Offered
Criminal justice (other than DUI/DWI)/Forensic clients; Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Clients who have experienced sexual abuse; Clients who have experienced intimate partner violence, domestic violence; Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for tobacco use
Testing
Breathalyzer or blood alcohol testing
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Housing services; Assistance with obtaining social services; Mentoring/peer support
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling; Family counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Children/Adolescents
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Mental health services; Integrated primary care services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Prescribes buprenorphine; Prescribes naltrexone; Lofexidine or Clonidine detoxification
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Lofexidine; Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State Substance use treatment agency; The Joint Commission
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicare; Medicaid; Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid; SAMHSA funding/block grants
Payment Assistance Available
Payment assistance (check with facility for details); Sliding fee scale (fee is based on income and other factors)
Special Programs/Groups Offered
Criminal justice (other than DUI/DWI)/Forensic clients; Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Clients who have experienced sexual abuse; Clients who have experienced intimate partner violence, domestic violence; Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for tobacco use
Testing
Breathalyzer or blood alcohol testing
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Housing services; Assistance with obtaining social services; Mentoring/peer support
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling; Family counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Children/Adolescents
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Mental health services; Integrated primary care services
